Evidence map›Paper›PMID 29651778›Full record

Trial reportApplied health economics and health policy2018

Cost-Consequence Analysis Alongside a Randomised Controlled Trial of Hospital Versus Telephone Follow-Up after Treatment for Endometrial Cancer.

Padraig Dixon, Kinta Beaver, Susan Williamson, Chris Sutton, Pierre Martin-Hirsch, William Hollingworth

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Applied health economics and health policy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 3 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 3 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Virtual Care in Patients with Cancer: A Systematic Review.Current oncology (Toronto, Ont.) · 2021
    Pooled it
  3. Pooled it
  4. Patient Voices: What Can We Learn From the Covid-19 Pandemic About Follow-Up Care in Gynaecologic Oncology?Health expectations : an international journal of public participation in health care and health policy · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Patient-Initiated Follow-Up in Ovarian Cancer.Current oncology (Toronto, Ont.) · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Padraig DixonPopulation Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK. Padraig.Dixon@bristol.ac.uk.ORCID 0000-0001-5285-409X
Kinta BeaverFaculty of Health and Wellbeing, University of Central Lancashire, Preston, PR1 2HE, UK.ORCID 0000-0002-6552-2323
Susan WilliamsonFaculty of Health and Wellbeing, University of Central Lancashire, Preston, PR1 2HE, UK.
Chris SuttonFaculty of Health and Wellbeing, University of Central Lancashire, Preston, PR1 2HE, UK.
Pierre Martin-HirschFaculty of Health and Wellbeing, University of Central Lancashire, Preston, PR1 2HE, UK.
William HollingworthPopulation Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK.
University of Lancashire · GBUniversity of Bristol · GBLancashire Teaching Hospitals NHS Foundation Trust · GB

Funding

Department of Health PB-PG-0610-22123Medical Research Council MC_UU_12013/1Medical Research Council MC_UU_12013/9Medical Research Council MR/P014259/1
6 · The paper itself

Abstract

backgroundRegular outpatient follow-up programmes are usually offered to patients following treatment for gynaecological and other cancers. Despite the substantial resources involved in providing these programmes, there is evidence that routine follow-up programmes do not affect survival or the likelihood of detecting recurrence and may not meet patient needs. Alternative follow-up modalities may offer the same outcomes at lower cost. We examined the costs of using telephone-based routine follow-up of women treated for endometrial cancer undertaken by specialist gynaecology oncology nurses in comparison to routine hospital-based follow-up.

methodsThe ENDCAT trial randomised 259 women at five centres in the north west of England with a known diagnosis of Stage I endometrial cancer who had completed primary treatment on a 1:1 basis to receive either standard hospital outpatient follow-up or a telephone follow-up intervention administered by specialist nurses. A cost-consequence analysis was undertaken in which we compared costs to the health system and to individuals with the trial's co-primary outcomes of psychological morbidity and participant satisfaction with information received.

resultsPsychological morbidity, psychosocial needs, patient satisfaction and quality of life did not differ between arms. Patients randomised to telephone follow-up underwent more and longer consultations. There was no difference in total health service mean per patient costs at 6 months (mean difference £8, 95% percentile confidence interval: - £147 to £141) or 12 months (mean difference: - £77, 95% percentile confidence interval: - £334 to £154). Estimated return journey costs per patient for hospital consultations were £11.47. Productivity costs were approximately twice as high under hospital follow-up.

conclusionTelephone follow-up was estimated to be cost-neutral for the NHS and may free up clinic time for other patients. There was some evidence that telephone follow-up may be more efficient for patients and wider society, and is not associated with additional psychological morbidity, lower patient satisfaction or reduced quality of life.

trial registrationISRCTN: 75220876, prospectively registered 28 October 2011.

Indexed as

Cost-Benefit AnalysisEndometrial NeoplasmsHospitalsPatient Reported Outcome MeasuresTelephoneAgedEnglandFemaleHumansMiddle AgedNeoplasm Recurrence, LocalPatient SatisfactionState MedicineTreatment Outcome

Identifiers

PMID29651778
PMCPMC5940716
OpenAlexW2796627256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.